October 19, 2021
Now available UPLIZNA®
UPLIZNA® (inebilizumab-cdon) injection, for intravenous use, is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. Hepatitis B Virus Screening Prior to initiating UPLIZNA, perform Hepatitis B virus (HBV) screening.
Please see full prescribing information.